Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Botulinum toxin in movement disorders.

Spiridon Papapetropoulos1, Carlos Singer

  • 1Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida 33136, USA.

Seminars in Neurology
|March 29, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.

Brain : a journal of neurology·2024
Same author

Factors affecting minority enrollment in Parkinson's disease genetic testing.

Parkinsonism & related disorders·2024
Same author

Validation of a New Patient-Reported Outcome Measure of the Functional Impact of Essential Tremor on Activities of Daily Living.

Tremor and other hyperkinetic movements (New York, N.Y.)·2024
Same author

Sustained Treatment Response and Global Improvements With Long-term Valbenazine in Patients With Tardive Dyskinesia.

Journal of clinical psychopharmacology·2024
Same author

Blepharoclonus in Parkinsonism.

Neurology. Clinical practice·2023
Same author

Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HT

Neurology. Clinical practice·2023
Same journal

Isolated Cranial Tremors: A Reappraisal.

Seminars in neurology·2026
Same journal

Dystonia and Tremor.

Seminars in neurology·2026
Same journal

Pendular nystagmus and oculopalatal tremor.

Seminars in neurology·2026
Same journal

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same journal

Tremor.

Seminars in neurology·2026
Same journal

Carotid Disease.

Seminars in neurology·2026
See all related articles

Botulinum toxin, used for muscle overactivity, offers effective and safe treatment for movement disorders beyond approved uses. Further clinical trials are needed to confirm efficacy in new neurological conditions.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Botulinum toxin blocks acetylcholine release at neuromuscular junctions, causing localized paralysis.
  • Serotypes A and B are established treatments for dystonia and spasticity.

Purpose of the Study:

  • To update on botulinum toxin applications in movement disorders.
  • To highlight treatment considerations for dystonic disorders.
  • To review off-label uses in neurology.

Main Methods:

  • Review of existing literature and clinical experience.
  • Analysis of approved and emerging indications for botulinum toxin.
  • Discussion of theoretical and practical treatment aspects.

Main Results:

  • Botulinum toxin is effective and safe for approved and many off-label movement disorder indications.

Related Experiment Videos

  • Established use in dystonia and spasticity.
  • Investigational use in tremor, tics, and myoclonus.

    • Conclusions:

    • Botulinum toxin demonstrates long-term efficacy and safety in movement disorders.
    • Expanded use beyond approved indications is promising but requires more research.
    • Controlled studies are needed for many off-label applications.